PIGU overexpression and regulation of cellular biological functions in bladder cancer

Read full text Summarise with VIRAT
Authors: Sheng-Hua Li, Zhi-Su Liu, Yu-Jia Chen, Jian-Di Li, Wei Long, Yi-Yang Chen, Wei Zhang, Zhi-Guang Huang, Zhen-Dong Chen, Gang Chen, Dan‐Ming Wei, Mo Zn
+1 more Li-Li Deng
Cited by: 0
References: 31

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

BACKGROUND PIGU has been proposed as a potential oncogene in bladder cancer (BLCA); however, experimental evidence regarding PIGU expression in BLCA remains lacking, necessitating further investigation into its functions and underlying mechanisms. AIM To explore the expression of PIGU in BLCA and to understand its function and underlying mechanisms. METHODS This study assessed PIGU protein expression in BLCA tissues via immunohistochemistry. We integrated 14 high-throughput datasets from TCGA, GEO, and Array Express to evaluate PIGU ’s mRNA expression levels and diagnostic efficacy. siRNA-knockdown cell lines were established using the PIGU -overexpressing HT-1376 BLCA cell line. Proliferation capacity was assessed via CCK-8 assays, while apoptosis and cell cycle distribution were evaluated using flow cytometry. PIGU’ s potential mechanism in BLCA were explored through differential gene enrichment analysis, protein interaction network analysis, and immune infiltration analysis. RESULTS PIGU expression was significantly upregulated in 121 BLCA and 32 non-BLCA samples at the protein level (10.65 ± 2.14 vs 5.56 ± 2.68, P < 0.0001) and in 1065 BLCA and 170 non-BLCA samples at the mRNA level (standardized mean difference = 0.74, 95% confidence interval: 0.07-1.41). Elevated PIGU expression correlated with poorer prognosis in BLCA patients, making it an independent prognostic factor. PIGU knockdown inhibited BLCA cell proliferation (P < 0.05), increased apoptosis, and caused cell cycle arrest at the G1 phase. PIGU -regulated genes are enriched in cell cycle pathways, with PCNA and MCM2 serving as hub genes. High PIGU expression was associated with reduced immune cell infiltration and higher tumor purity, potentially promoting immune evasion through VTCN1 activation and ICOS inhibition. CONCLUSION PIGU is upregulated in BLCA and has prognostic value. It promotes tumor progression by regulating the cell cycle and immune microenvironment, showing potential as an effective therapeutic target for BLCA.

Fields of Study & Subjects

Bladder and Urothelial Cancer Treatments Cancer-related molecular mechanisms research Urinary Bladder and Prostate Research

Publication details

Journal / source
World Journal of Clinical Oncology
Volume
17
Issue
3
Publication date
23 March 2026
Language
EN